Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
Articles
Page 21 of 23
-
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P47
-
Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P45 -
CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P43 -
Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P41 -
Exploring Kaposi's sarcoma-associated herpesvirus latent genes' role in viral lymphomagenesis using transgenic mice
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P39 -
Kaposi's sarcoma human herpesvirus K1 interferes with FAS-mediated apoptosis and stimulates clonal growth and lymphoid hyperplasia
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P37 -
Cellular gene regulation by K13/VFLIP of Kaposi's sarcoma-associated herpesvirus
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P35 -
HIV-associated bladder cancer: diagnosis and management
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P34 -
Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P33 -
Colon adenocarcinoma in HIV infected patients
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P32 -
Protein tyrosine phosphatase nonreceptor 13 (PTPN13) is targeted by human papillomavirus 16 E6 in cervical epithelium
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P31 -
Extracellular matrix promotes pathogenic treatment of AIDS-associated Kaposi's sarcoma at Hôpital General in Yaoundé, Cameroon
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P30 -
AKT/TSC/mTOR activation by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: novel therapeutic targets for the treatment of Kaposi's sarcoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P29 -
Genetic resistance to GAHV-2 induced lymphoma in the chicken model
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P28 -
Genetically restricted HIV-1 sub populations are associated with and migrate within metastatic sites of AIDS-related lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P27 -
MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P26 -
Risk of death among Italian AIDS cases with AIDS-defining cancers in the post-HAART era
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O25 -
Tobacco, alcohol and use of other recreational drugs within HIV-infected treated cohorts: the IeDEA West Africa collaboration
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P24 -
Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-associated non-Hodgkin's lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O24 -
Profiling viral and host microRNA expression in cells infected with KSHV and EBV
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O23 -
Burkitt lymphoma in Brazil is characterized by geographically distinct clinico-pathological features and lack of p53 mutations
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P22 -
Implementation of a "see and treat" cervical cancer prevention program linked to HIV care in Zambia
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O21 -
KSHV seroprevalence, and blood and saliva viral loads in the HIV-infected population of south Texas
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P20 -
Profiling of cellular and viral microRNAs in Kaposi sarcoma and viral-associated lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O19 -
Kaposi's sarcoma-associated herpes virus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P18 -
Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O17 -
Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O16 -
Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P16 -
Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O15 -
Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O14 -
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS malignancies consortium clinical trials 010 and 034
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P14 -
Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P13 -
Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O12 -
Regulatory T cells are present in Kaposi's sarcoma and increasingly frequent in advanced disease
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P12 -
Epidemiology of non-keratinocytic skin cancers among persons with AIDS in the United States
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O10 -
Survival and prognosis of HIV-associated non-Hodgkin-lymophma in the era of combined anti-retroviral therapy, a European multi-cohort study
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P10 -
Dendritic cell-mediated infection of primary B cells with KSHV
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P9 -
Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O9 -
Evaluation of Epstein-Barr virus (EBV) and human herpes virus-8 (HHV-8) in HIV-associated persistent generalized lymphadenopathy (PGL)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P7 -
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O7 -
Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P6 -
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O6 -
AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O5 -
Suppression of galectin-3 in KSHV infected DMVEC cells and Kaposi's sarcoma: implications for tumorigenesis
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P5 -
Malignancies in HIV infected children at a tertiary cancer hospital in India
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P4 -
Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O3 -
Four year survival in untreated AIDS related-Kaposi sarcoma (AIDS-KS) in Jos, Nigeria
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P3 -
Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O2 -
Development and application of a real time PCR assay for detection and quantification of merkel cell virus (MCV) in archived formalin fixed paraffin embedded tissue samples of merkel cell carcinoma and other cancers
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O1 -
A retrospective analysis of HIV-associated Kaposi's sarcoma in patients with non-detectable HIV viral loads and CD4+ counts greater than 300 cells/μL
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P1
-
Affiliated with
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.1
5-year Journal Impact Factor: 3.3
Source Normalized Impact per Paper (SNIP): 0.810
SCImago Journal Rank (SJR): 0.424Speed 2023
Submission to first editorial decision (median days): 12
Submission to acceptance (median days): 112Usage 2023
Downloads: 687,750
Altmetric mentions: 813
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.